Recruiting Heart Attack Studies in Hemet
A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe Systemic Lupus Erythematosus (SLE) population....
A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2)
The purpose of this study is to evaluate the efficacy and safety of telitacicept in the treatment of moderately to severely active SLE....
About Heart Attack Clinical Trials in Hemet
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
There are currently 2 heart attack clinical trials recruiting participants in Hemet, CA. These studies are seeking a combined 840 participants. Research is being sponsored by Bristol-Myers Squibb, RemeGen Co., Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Attack Clinical Trials in Hemet — FAQ
Are there heart attack clinical trials in Hemet?
Yes, there are 2 heart attack clinical trials currently recruiting in Hemet, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Hemet?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hemet research site will contact you about next steps.
Are clinical trials in Hemet free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hemet studies also compensate for your time and travel.
What heart attack treatments are being tested?
The 2 active trials in Hemet are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.
Data updated March 2, 2026 from ClinicalTrials.gov